Primary Care Providers are Rapidly Adopting Digital Medicine Study Shows

QHSLab, Inc. is leading the way in assisting independent practices to embrace reimbursable non-face-to-face digital health tools for efficient clinical decision support and patient care coordination. Invest in the Future of Medicine with QHSLab, Inc. (USAQ)

We know that medical technology has been at the forefront of healthcare for quite some time. Still, throughout the last five years, physicians have dramatically increased the adoption rate of medical technology among healthcare providers. As a result, the American Medical Association (AMA) has conducted a study spanning from 2019-2022, cataloging the sentiments of physicians regarding such technology adoption. Even before the COVID-19 pandemic, there was heightened motivation to adopt digital medicine tools, recognizing the benefits to their practice, profits, and peace of mind.

First, what is "digital medicine?” According to the Digital Medicine Society, "Digital medicine describes a field concerned with the use of technologies as tools for measurement and intervention in the service of human health." 

In summation, the recent AMA survey showed the following:

• Physicians who think digital health tools are an advantage for patient care grew from 85% in 2016 to 93% in 2022 across all practice areas and all practitioners.

• The number of digital tools used by physicians grew from an average of 2.2 to 3.8 in 2022.

• The top reported reason for adopting additional digital medicine tools was to improve clinical outcomes and reduce administrative burdens.

• The most significant growth in adoption was among digital health tools that aid in remote non face to face care, jumping from 14% to 80%. 

• The digital health tools garner the most enthusiasm among physicians are televisits (57%), followed by remote monitoring devices (53%).

AMA President Jack Resneck, Jr., MD, stated, "The AMA survey illustrates the importance physicians place on validated digital health tools that improve health while streamlining the technological and administrative burdens faced daily in medicine. However, these technologies also must be designed and deployed in ways that advance health equity."

How is QHSLab, Inc. positioned to meet this demand?

QHSLab is a unique, cloud-based medical office and mobile patient education solution that provides physicians with a robust digital health platform to streamline patient information and business operations. Through Artificial Intelligence (AI) technology, QHSLab engages individual patients before or after scheduled office visits, generating relevant data to maximize the time of in-person encounters. QHSLab also provides follow-up patient education in the form of e-visits between face-to-face appointments. These services are reimbursable through proven CPT codes, improving clinical outcomes, reducing administrative burdens, and creating new revenue streams.

QHSLab aims to reduce the practice's non-clinical workload and enhance the patient-provider relationship while offering the provider a complete clinical decision support and care coordination tool. QHSLab's proprietary digital software frees up clinical time on non-clinical tasks, offers automated medical guideline-based suggestions, and enhances patient and physician experience and satisfaction.

QHSLab has a variety of health and condition-specific, reimbursable assessments, including the current four core digital assessments covering 100% of patients seen in primary care: 

• Post-COVID-19 Assessment: The Post-COVID-19 Health Habits Assessment combines the Post-COVID-19 Functional Status (PCFS) scale, designed to assess the functional status of patients previously infected with SARS-CoV-2 virus, with an assessment of your patient's current personal health and lifestyle habits including stress management, fruit, and vegetable consumption, exercise, tobacco use, and alcohol consumption.

• Quality of Life "Q-Scale" Mental Health Assessment: The Quality of Life Scale, "Q-Scale," measures a patient's responses or early warning signs to questions about their sleep, stress, anxiety, worry, pain, and satisfaction. Patients identified as having high mental health risks are flagged for further screening.

• Allergies and Asthma Assessment: This assessment tracks patient responses to allergy symptoms, triggers, history, and severity scores for the SNOT-22, Asthma Control, and Respiratory Allergy Prediction.

• Medical Nutrition Assessment: This assessment provides dietary risk scoring and identifies opportunities for medical nutrition therapy and weight control management, tracking dietary variety, fiber, omega-3, fat, and fluids intake.

QHSLab's tools help support clinical decision-making by reducing the burden of non-clinical tasks, offering automated medical guideline-based suggestions, and enhancing patient and physician experience and satisfaction. The suite of digital health tools from QHSLab optimizes the practice workflow with no changes to their EHR required and little to no additional work for administrative staff. QHSLab continuously reviews payer criteria based on the relevant CPT code guidelines, proactively addressing changes that may affect reimbursements.

At QHSLab, Inc., we shape the future of medicine through digital medicine tools that help primary care physicians improve clinical outcomes and streamline their practice workflow. 

Medical Technology and Digital Health companies are usually eaten up by Wall Street and venture capital firms, providing little opportunity for retail investors. An early investment in QHSLab, Inc. is an opportunity to beat the VCs and Wall Street and secure equity in the booming digital health and physician services market. 

Discover why an investment made today will shape the #FutureofMedicine for generations to come.